ViroGates A/S Logo

ViroGates A/S

Develops suPAR diagnostic tests for inflammation risk assessment in acute care and longevity.

VIRO | ST

Overview

Corporate Details

ISIN(s):
DK0061030574
LEI:
5493007TX8XS56RMZD94
Country:
Denmark
Address:
Banevænget 13 1., 3460 Birkerød
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ViroGates A/S is an international medical technology company that develops and markets in vitro diagnostic blood tests for measuring chronic inflammation. Founded in 2000, its core technology is centered on the prognostic biomarker suPAR (soluble urokinase Plasminogen Activator Receptor). The company's products are sold under the suPARnostic® brand and are used for health risk assessment and to support clinical decision-making. Key markets include acute care, where the tests enhance patient triage and risk stratification; longevity, for assessing inflammation-driven aging and guiding personalized preventative care; and clinical research, to optimize patient selection and monitor intervention outcomes. The suPARnostic® product suite includes the Quick Triage point-of-care test, the Turbi-Latex solution for automated systems, and an ELISA assay for clinical and research applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-12-17 11:01
Earnings Release
English 134.5 KB
2024-12-17 11:01
Regulatory News Service
Danish 429.4 KB

Automate Your Workflow. Get a real-time feed of all ViroGates A/S filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ViroGates A/S via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Fine Foods & Pharmaceuticals Ntm Logo
Contract development & manufacturing of oral solids for pharma, nutraceutical & cosmetic sectors.
Italy FF
Formycon AG Logo
Develops cost-effective biosimilars for ophthalmology, immunology, and other chronic diseases.
Germany FYB
Friulchem Logo
CDMO for animal health, providing vet pharma & supplement solutions for pets and livestock.
Italy FCM
Fuji Pharma Co.,Ltd. Logo
Specializes in hormone medicines for ob/gyn, injectables, and contract manufacturing.
Japan 4554
Fuso Pharmaceutical Industries,Ltd. Logo
Manufactures essential pharmaceuticals like dialysis drugs, infusions, and injections for healthcare.
Japan 4538
FutureChem Co., Ltd. Logo
Develops radiopharmaceuticals & diagnostic agents for cancer, Alzheimer's, and Parkinson's disease.
South Korea 220100
Future Medicine  Co., Ltd. Logo
Clinical-stage biopharma developing novel synthetic drugs for inflammation, fibrosis, and oncology.
South Korea 341170
Develops long-acting injectable therapies for chronic diseases and cancer.
South Korea 456160
Gabather AB Logo
Developing novel GABAA receptor drugs for neuropsychiatric disorders.
Sweden GABA
Galapagos NV Logo
Biotech firm developing novel CAR-T cell therapies for oncology via a rapid delivery platform.
Belgium GLPG

Talk to a Data Expert

Have a question? We'll get back to you promptly.